SCM
CLCD

Segantii Capital Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Segantii Capital Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,200
Closed -$81K – 405
2016
Q4 		$81K Buy
+2,200
New +$77.8K 0.02% 66

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Segantii Capital Management's CLCD Position: Q1 2017 in Review

Segantii Capital Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 2,200 shares — an estimated $81K sold.

Segantii Capital Management first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $81K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Segantii Capital Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Segantii Capital Management sold 2,200 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $81K.
  • Segantii Capital Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Segantii Capital Management's CoLucid Pharmaceuticals, Inc. position peaked at $81K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Segantii Capital Management's 13F filing for Q1 2017, filed 12 May 2017.